Literature DB >> 30102335

CharGer: clinical Characterization of Germline variants.

Adam D Scott1,2, Kuan-Lin Huang1,2, Amila Weerasinghe1,2, R Jay Mashl1,2, Qingsong Gao1,2, Fernanda Martins Rodrigues1,2, Matthew A Wyczalkowski1,2, Li Ding1,2,3,4.   

Abstract

SUMMARY: CharGer (Characterization of Germline variants) is a software tool for interpreting and predicting clinical pathogenicity of germline variants. CharGer gathers evidence from databases and annotations, provided by local tools and files or via ReST APIs, and classifies variants according to ACMG guidelines for assessing variant pathogenicity. User-designed pathogenicity criteria can be incorporated into CharGer's flexible framework, thereby allowing users to create a customized classification protocol.
AVAILABILITY AND IMPLEMENTATION: Source code is freely available at https://github.com/ding-lab/CharGer and is distributed under the GNU GPL-v3.0 license. Software is also distributed through the Python Package Index (PyPI) repository. CharGer is implemented in Python 2.7 and is supported on Unix-based operating systems. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Mesh:

Year:  2019        PMID: 30102335      PMCID: PMC6394391          DOI: 10.1093/bioinformatics/bty649

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  14 in total

1.  Genomic and evolutionary classification of lung cancer in never smokers.

Authors:  Tongwu Zhang; Philippe Joubert; Naser Ansari-Pour; Wei Zhao; Phuc H Hoang; Rachel Lokanga; Aaron L Moye; Jennifer Rosenbaum; Abel Gonzalez-Perez; Francisco Martínez-Jiménez; Andrea Castro; Lucia Anna Muscarella; Paul Hofman; Dario Consonni; Angela C Pesatori; Michael Kebede; Mengying Li; Bonnie E Gould Rothberg; Iliana Peneva; Matthew B Schabath; Maria Luana Poeta; Manuela Costantini; Daniela Hirsch; Kerstin Heselmeyer-Haddad; Amy Hutchinson; Mary Olanich; Scott M Lawrence; Petra Lenz; Maire Duggan; Praphulla M S Bhawsar; Jian Sang; Jung Kim; Laura Mendoza; Natalie Saini; Leszek J Klimczak; S M Ashiqul Islam; Burcak Otlu; Azhar Khandekar; Nathan Cole; Douglas R Stewart; Jiyeon Choi; Kevin M Brown; Neil E Caporaso; Samuel H Wilson; Yves Pommier; Qing Lan; Nathaniel Rothman; Jonas S Almeida; Hannah Carter; Thomas Ried; Carla F Kim; Nuria Lopez-Bigas; Montserrat Garcia-Closas; Jianxin Shi; Yohan Bossé; Bin Zhu; Dmitry A Gordenin; Ludmil B Alexandrov; Stephen J Chanock; David C Wedge; Maria Teresa Landi
Journal:  Nat Genet       Date:  2021-09-06       Impact factor: 38.330

2.  Genomic Profiling of Lung Adenocarcinoma in Never-Smokers.

Authors:  Siddhartha Devarakonda; Yize Li; Fernanda Martins Rodrigues; Sumithra Sankararaman; Humam Kadara; Chandra Goparaju; Irena Lanc; Kymberlie Pepin; Saiama N Waqar; Daniel Morgensztern; Jeffrey Ward; Ashiq Masood; Robert Fulton; Lucinda Fulton; Michael A Gillette; Shankha Satpathy; Steven A Carr; Ignacio Wistuba; Harvey Pass; Richard K Wilson; Li Ding; Ramaswamy Govindan
Journal:  J Clin Oncol       Date:  2021-09-30       Impact factor: 44.544

3.  Proteogenomic characterization of pancreatic ductal adenocarcinoma.

Authors:  Liwei Cao; Chen Huang; Daniel Cui Zhou; Yingwei Hu; T Mamie Lih; Sara R Savage; Karsten Krug; David J Clark; Michael Schnaubelt; Lijun Chen; Felipe da Veiga Leprevost; Rodrigo Vargas Eguez; Weiming Yang; Jianbo Pan; Bo Wen; Yongchao Dou; Wen Jiang; Yuxing Liao; Zhiao Shi; Nadezhda V Terekhanova; Song Cao; Rita Jui-Hsien Lu; Yize Li; Ruiyang Liu; Houxiang Zhu; Peter Ronning; Yige Wu; Matthew A Wyczalkowski; Hariharan Easwaran; Ludmila Danilova; Arvind Singh Mer; Seungyeul Yoo; Joshua M Wang; Wenke Liu; Benjamin Haibe-Kains; Mathangi Thiagarajan; Scott D Jewell; Galen Hostetter; Chelsea J Newton; Qing Kay Li; Michael H Roehrl; David Fenyö; Pei Wang; Alexey I Nesvizhskii; D R Mani; Gilbert S Omenn; Emily S Boja; Mehdi Mesri; Ana I Robles; Henry Rodriguez; Oliver F Bathe; Daniel W Chan; Ralph H Hruban; Li Ding; Bing Zhang; Hui Zhang
Journal:  Cell       Date:  2021-09-16       Impact factor: 66.850

4.  Comprehensive characterization of 536 patient-derived xenograft models prioritizes candidatesfor targeted treatment.

Authors:  Hua Sun; Song Cao; R Jay Mashl; Chia-Kuei Mo; Simone Zaccaria; Michael C Wendl; Sherri R Davies; Matthew H Bailey; Tina M Primeau; Jeremy Hoog; Jacqueline L Mudd; Dennis A Dean; Rajesh Patidar; Li Chen; Matthew A Wyczalkowski; Reyka G Jayasinghe; Fernanda Martins Rodrigues; Nadezhda V Terekhanova; Yize Li; Kian-Huat Lim; Andrea Wang-Gillam; Brian A Van Tine; Cynthia X Ma; Rebecca Aft; Katherine C Fuh; Julie K Schwarz; Jose P Zevallos; Sidharth V Puram; John F Dipersio; Brandi Davis-Dusenbery; Matthew J Ellis; Michael T Lewis; Michael A Davies; Meenhard Herlyn; Bingliang Fang; Jack A Roth; Alana L Welm; Bryan E Welm; Funda Meric-Bernstam; Feng Chen; Ryan C Fields; Shunqiang Li; Ramaswamy Govindan; James H Doroshow; Jeffrey A Moscow; Yvonne A Evrard; Jeffrey H Chuang; Benjamin J Raphael; Li Ding
Journal:  Nat Commun       Date:  2021-08-24       Impact factor: 17.694

5.  TAPES: A tool for assessment and prioritisation in exome studies.

Authors:  Alexandre Xavier; Rodney J Scott; Bente A Talseth-Palmer
Journal:  PLoS Comput Biol       Date:  2019-10-15       Impact factor: 4.475

6.  Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing.

Authors:  Guan-Tian Lang; Yi-Zhou Jiang; Jin-Xiu Shi; Fan Yang; Xiao-Guang Li; Yu-Chen Pei; Chen-Hui Zhang; Ding Ma; Yi Xiao; Peng-Chen Hu; Hai Wang; Yun-Song Yang; Lin-Wei Guo; Xun-Xi Lu; Meng-Zhu Xue; Peng Wang; A-Yong Cao; Hong Ling; Zhong-Hua Wang; Ke-Da Yu; Gen-Hong Di; Da-Qiang Li; Yun-Jin Wang; Ying Yu; Le-Ming Shi; Xin Hu; Wei Huang; Zhi-Ming Shao
Journal:  Nat Commun       Date:  2020-11-10       Impact factor: 14.919

7.  Genetic landscape of external auditory canal squamous cell carcinoma.

Authors:  Kuniaki Sato; Noritaka Komune; Takahiro Hongo; Kensuke Koike; Atsushi Niida; Ryutaro Uchi; Teppei Noda; Ryunosuke Kogo; Nozomu Matsumoto; Hidetaka Yamamoto; Muneyuki Masuda; Yoshinao Oda; Koshi Mimori; Takashi Nakagawa
Journal:  Cancer Sci       Date:  2020-07-11       Impact factor: 6.716

8.  Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.

Authors:  Jason E McDermott; Osama A Arshad; Vladislav A Petyuk; Yi Fu; Marina A Gritsenko; Therese R Clauss; Ronald J Moore; Athena A Schepmoes; Rui Zhao; Matthew E Monroe; Michael Schnaubelt; Chia-Feng Tsai; Samuel H Payne; Chen Huang; Liang-Bo Wang; Steven Foltz; Matthew Wyczalkowski; Yige Wu; Ehwang Song; Molly A Brewer; Mathangi Thiagarajan; Christopher R Kinsinger; Ana I Robles; Emily S Boja; Henry Rodriguez; Daniel W Chan; Bing Zhang; Zhen Zhang; Li Ding; Richard D Smith; Tao Liu; Karin D Rodland
Journal:  Cell Rep Med       Date:  2020-04-10

9.  Ancestry-specific predisposing germline variants in cancer.

Authors:  Ninad Oak; Andrew D Cherniack; R Jay Mashl; Fred R Hirsch; Li Ding; Rameen Beroukhim; Zeynep H Gümüş; Sharon E Plon; Kuan-Lin Huang
Journal:  Genome Med       Date:  2020-05-29       Impact factor: 15.266

10.  Non-cancer-related pathogenic germline variants and expression consequences in ten-thousand cancer genomes.

Authors:  Zishan Wang; Xiao Fan; Yufeng Shen; Meghana S Pagadala; Rebecca Signer; Kamil J Cygan; William G Fairbrother; Hannah Carter; Wendy K Chung; Kuan-Lin Huang
Journal:  Genome Med       Date:  2021-09-09       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.